Target intelligence / Profile preview

Phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3) (PIK3C3)

Target
PIK3C3
Molecular classification
Enzyme, Kinase, Phosphoinositide 3-kinase, Lipid kinase
01

Overview

Class III Phosphoinositide 3-kinase (PI3K), primarily known by its catalytic subunit VPS34 (PIK3C3), is a lipid kinase that specifically phosphorylates phosphatidylinositol to generate phosphatidylinositol 3-phosphate (PtdIns3P). This signaling lipid is a fundamental regulator of intracellular membrane trafficking, playing a central role in the initiation of autophagy, endosome maturation, and phagocytosis [UniProt: Q8NEB9]. By recruiting effector proteins that recognize PtdIns3P, VPS34 facilitates the formation of autophagosomes and the sorting of cargo within the endolysosomal system. In oncology, VPS34 is frequently exploited by tumor cells to survive metabolic stress and evade immune surveillance, making it a significant target for small-molecule inhibitors like SAR405 [PubMed: 24679539]. Conversely, its dysfunction is implicated in neurodegenerative diseases where the failure of autophagic clearance leads to the accumulation of toxic protein aggregates. Therapeutic development currently focuses on selective VPS34 inhibitors to sensitize tumors to chemotherapy and modulate the tumor microenvironment.

Other names
VPS34Class III phosphoinositide 3-kinasehVps34Phosphoinositide-3-kinase class 3Vacuolar protein sorting-associated protein 34
02

Mechanism of action

Inhibition of the catalytic activity of VPS34 prevents the phosphorylation of phosphatidylinositol to phosphatidylinositol 3-phosphate (PtdIns3P), thereby blocking the recruitment of FYVE and PX domain-containing proteins essential for autophagosome formation and endosomal maturation [PubMed: 24679539, 25130555].

03

Biological functions

AutophagyEndosomal traffickingVesicle-mediated transportPhagocytosisNutrient sensingCiliogenesis
04

Disease associations

CancerNeurodegenerative diseaseInfectionInflammatory diseaseCardiovascular disease
05

Safety considerations

Disruption of basal autophagy leading to proteotoxicityPotential neurotoxicity due to impaired protein aggregate clearanceSystemic toxicity from interference with essential endosomal sortingModulation of immune cell function and cytokine secretion
06

Interacting drugs

SAR405

6 more in the full profile.

07

Biomarkers

PtdIns3P levelsLC3-II/LC3-I ratiop62 (SQSTM1) protein accumulationFYVE-domain protein localizationWIPI2 puncta formation

Beyond the preview

Go deeper on Phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3) (PIK3C3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3) (PIK3C3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call